Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma

M. Lopez, L. Di Lauro, P. Papaldo, F. Ganzina, N. Di Pietro, B. Lazzaro

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{f76d3d2566854dcd9106e212ecc70547,

title = "Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma",

author = "M. Lopez and {Di Lauro}, L. and P. Papaldo and F. Ganzina and {Di Pietro}, N. and B. Lazzaro",

year = "1986",

language = "English",

volume = "70",

pages = "911--912",

journal = "Cancer Treatment Reports",

issn = "0361-5960",

publisher = "U.S. National Cancer Institute",

number = "7",

}

TY - JOUR

T1 - Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma

AU - Lopez, M.

AU - Di Lauro, L.

AU - Papaldo, P.

AU - Ganzina, F.

AU - Di Pietro, N.

AU - Lazzaro, B.

PY - 1986

Y1 - 1986

UR - http://www.scopus.com/inward/record.url?scp=0022469154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022469154&partnerID=8YFLogxK

M3 - Article

C2 - 3459575

AN - SCOPUS:0022469154

VL - 70

SP - 911

EP - 912

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

SN - 0361-5960

IS - 7

ER -